Excessive Mood Elevation and Behavioral Activation with Antidepressant Treatment of Juvenile Depressive and Anxiety Disorders: A Systematic Review

@article{Offidani2013ExcessiveME,
  title={Excessive Mood Elevation and Behavioral Activation with Antidepressant Treatment of Juvenile Depressive and Anxiety Disorders: A Systematic Review},
  author={E. Offidani and G. Fava and E. Tomba and R. Baldessarini},
  journal={Psychotherapy and Psychosomatics},
  year={2013},
  volume={82},
  pages={132 - 141}
}
Background: The prevalence, characteristics and implications of excessive arousal-activation in children and adolescents treated with antidepressants for specific illnesses have not been systematically examined. Methods: We compared reports of antidepressant trials (n = 6,767 subjects) in juvenile depressive (n = 17) and anxiety disorders (n = 25) for consensus-based indications of psychopathological mood elevation or behavioral activation. Results: Rates of excessive arousal-activation during… Expand

Paper Mentions

Antidepressants increase risk of behavioural symptoms in children and adolescents with depression or anxiety
TLDR
The need for more reliable and consistent measures of activation and mania-hypomania, the need for biomarkers and pharmacokinetic studies that predict activation or mania, and consideration of the use of psychotherapeutic alternatives, when clinically appropriate, in anxious youth and those at risk for mania are supported. Expand
Pharmacological treatment of children and adolescents with depression
TLDR
Considering both the high response to non-specific interventions and safety concerns, antidepressants should be used cautiously in youth, and limited to patients with moderate-to-severe depression for whom psychosocial interventions are either ineffective or not feasible. Expand
Antidepressant-associated mood-switching and transition from unipolar major depression to bipolar disorder: a review.
TLDR
AD-treatment was associated with new mania-like responses in 8.18% of patients diagnosed with unipolar MDD and later diagnosis of BPD not associated with AD-treatment, and there was little information on predictive associations between mood-switches and BPD-diagnosis. Expand
Mixed Depression: Clinical Features and Predictors of Its Onset Associated with Antidepressant Use
TLDR
A clinical description for defining MxD, defined as depression with excitatory symptoms, can be clinically identified, is common, occurs in both unipolar depression and bipolar disorder, and is frequently associated with antidepressant use. Expand
The Risks and Benefits of Antidepressants to Treat Pediatric-Onset Depression and Anxiety Disorders: A Developmental Perspective
  • J. Leckman
  • Medicine, Psychology
  • Psychotherapy and Psychosomatics
  • 2013
TLDR
The systematic review by Offidani et al. provides a sobering and compelling reminder that the use of these agents in children and adolescents is associated with a substantial risk of adverse effects characterized by excessive emotional arousal or behavioral activation including mania and hypomania. Expand
Antidepressant-Induced Activation in Children and Adolescents: Risk, Recognition and Management.
TLDR
The pathophysiology of antidepressant-related activation, predictors of activation and its clinical management in youth with depressive and anxiety disorders who are treated with antidepressant medications are described. Expand
SSRI-Induced Activation Syndrome in Children and Adolescents—What Is Next?
Opinion statementAntidepressants are being increasingly prescribed for children and adolescents for the treatment of depression, anxiety, and other mental disorders. The selective serotonin reuptakeExpand
Psychological therapy for anxiety in bipolar spectrum disorders: a systematic review.
TLDR
Evidence for the effectiveness of psychological therapy for anxiety in adults with bipolar spectrum disorders is reviewed, and preliminary evidence is promising for CBT for post-traumatic stress disorder and generalised anxiety disorder in BPSD. Expand
Antidepressant-induced hypomania/mania in patients with major depression: Evidence from the BRIDGE-II-MIX study.
TLDR
The results of the BRIDGE-II-MIX study strongly support the DSM-5 inclusion of MDD patients with AIHM within the rubric of bipolar disorder. Expand
Efficacy and Tolerability of Benzodiazepines versus Antidepressants in Anxiety Disorders: A Systematic Review and Meta-Analysis
TLDR
The role and usefulness of BDZ need to be reappraised and no consistent evidence emerged supporting the advantage of using TCA over BDZ in treating generalized anxiety disorder, complex phobias and mixed anxiety-depressive disorders. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 122 REFERENCES
Efficacy of antidepressants in juvenile depression: meta-analysis
TLDR
Antidepressants of all types showed limited efficacy in juvenile depression, but fluoxetine might be more effective, especially in adolescents. Expand
Bipolar depression: clinical correlates of receiving antidepressants.
TLDR
Use of ADs to treat acute BP-depression was very common and associated with a more severe clinical history, and Mood-switching was prevalent with AD-treatment even with mood-stabilizers present. Expand
Effectiveness and tolerability of citalopram for the treatment of depression and anxiety disorders in children and adolescents: an open-label study
TLDR
Citalopram was moderately effective, generally well tolerated and safe for the acute treatment of depressed and anxious children and adolescents. Expand
Sertraline for Major Depression in Children and Adolescents: Preliminary Clinical Experience
ABSTRACT Objective: To evaluate the therapeutic and adverse effects of sertraline in children and adolescents with major depressive disorder (MDD). Method: Retrospective chart reviews were conductedExpand
Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety.
TLDR
Both cognitive behavioral therapy and sertraline reduced the severity of anxiety in children with anxiety disorders; a combination of the two therapies had a superior response rate. Expand
Efficacy of paroxetine in the treatment of adolescent major depression: a randomized, controlled trial.
TLDR
Paroxetine demonstrated significantly greater improvement compared with placebo in Hamilton Rating Scale for Depression total score < or = 8, HAM-D depressed mood item, K-SADS-L depressed Mood item, and CGI score of 1 or 2. Expand
Selective serotonin reuptake inhibitor use in the treatment of the pediatric non-obsessive-compulsive disorder anxiety disorders.
  • L. Seidel, J. Walkup
  • Psychology, Medicine
  • Journal of child and adolescent psychopharmacology
  • 2006
TLDR
Available studies on the treatment of non-OCD childhood anxiety disorders with antidepressants, including the SSRIs, are reviewed, and pertinent safety issues are discussed and the benefit/risk ratio for anxiety disorders is more favorable than that for depression. Expand
Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial.
TLDR
The combination of fluoxetine with CBT offered the most favorable tradeoff between benefit and risk for adolescents with major depressive disorder. Expand
Efficacy and safety of antidepressant drug treatment in children and adolescents
TLDR
A series of published and unpublished efficacy and safety data regarding antidepressant use in children and adolescents suggests that these medications may offer mild-to-moderate benefit, with notable exceptions depending on medication and indication, but they may also heighten the risk for suicidal ideation and parasuicidal behavior. Expand
Fluoxetine for the treatment of childhood anxiety disorders.
TLDR
Familiarity of the anxiety at intake and positive family history for anxiety predicted poorer functioning at the end of the study, and fluoxetine was useful and well tolerated except for mild and transient headaches and gastrointestinal side effects. Expand
...
1
2
3
4
5
...